Persistent smoking by Japanese patients within four years from diagnosis of chronic obstructive pulmonary disease

Addictive Behaviors

Volumn 33, Issue 9, 2008, Pages 1235-1238

  Hirayama, Fumi ^a,b   Lee, Andy H ^a,b   Binns, Colin W ^a,b   Tanikawa, Yoshimasa ^c  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c Aichi Prefectural Welfare Federation of Agricultural Cooperatives   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Cigarette consumption; Severity; Smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DISEASE SEVERITY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SMOKING;

AGED; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 46049089399     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2008.04.014     Document Type: Article

References (11)

1. Coultas D.B., Edwards D.W., Barnett B., and Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD 4 1 (2007) 23-28
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - Executive summary (2006). http://www.goldcopd.dk/index_uk.htm http://www.goldcopd.dk/index_uk.htm
3. Jian L., Binns C.W., and Lee A.H. Validity of a food-frequency questionnaire for elderly men in southeast China. Public Health Nutrition 9 7 (2006) 928-933
4. Karadag F., Karul A.B., Cildag O., Altun C., and Gurgey O. Determinants of BMI in patients with COPD. Respirology 9 1 (2004) 70-75
5. Kojima S., Sakakibara H., Motani S., Hirose K., Mizuno F., Ochiai M., and Hashimoto S. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. Journal of Epidemiology 17 2 (2007) 54-60
6. Lindberg A., Larsson L.G., Ronmark E., Jonsson A.C., Larsson K., and Lundback B. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 4 1 (2007) 5-13
7. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine 163 5 (2001) 1256-1276
8. Soriano J.B., Sin D.D., Zhang X., Camp P.G., Anderson J.A., Anthonisen N.R., Buist A.S., Burge P.S., Calverley P.M., Connett J.E., Petersson S., Postma D.S., Szafranski W., and Vestbo J. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest 131 3 (2007) 682-689
9. Tabak C., Smit H.A., Rasanen L., Fidanza F., Menotti A., Nissinen A., Feskens E.J., Heederik D., and Kromhout D. Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. Epidemiology 12 2 (2001) 239-245
10. Teramoto S., Yamamoto H., Yamaguchi Y., Matsuse T., and Ouchi Y. Global burden of COPD in Japan and Asia. Lancet 362 9397 (2003) 1764-1765
11. The Japanese Respiratory Society. Guidelines for the diagnosis and treatment of COPD (chronic obstructive pulmonary disease) (2004), Medical Review Co Ltd, Tokyo 6-17